Skip to main content

Table 2 Medical history and clinical features among cases group

From: The assessment of pentraxin 3: a diagnostic and prognostic biomarker in lower respiratory tract infections in children

Variables

(n = 60)

Description

Site of admission

N

%

Ward

18

30%

PICU

22

36.7%

Intermediate care

20

33.3%

Presentation

N

%

Dyspnea

60

100%

Cough

56

93.3%

Poor oral intake

52

86.7%

Rhinorrhea

22

36.7%

Vomiting

22

36.7%

General examination

Median

(Range)

Duration of fever (days)

4.5

(1–14)

Peak body temperature (°C)

38.3

(37–40)

Respiratory rate (breaths/min)

60

(44–80)

Heart rate (beats/min)

116

(98–136)

PRESS

3

(0–5)

O2 saturation (%)

90

(70–96)

Hospital stay duration (days)

16

(4–27)

Chest Examination

N

%

Crepitations

56

93.3%

Diminished air entry

46

76.7%

Wheezes

40

66.7%

Respiratory failure

18

30%

Diagnosis

N

%

Pneumonia

38

63.3%

Bronchiolitis

6

10%

VAP

10

16.7%

PPE

6

10%

Management

N

%

O2 Support

60

100%

Mechanical ventilation

18

30%

IV fluid

52

86.7%

Outcome

N

%

Discharged

58

96.7%

Died

2

3.3%

  1. PICU: Pediatric intensive care unit, VAP: Ventilator-associated pneumonia, IV: Intravenous, PRESS: Pediatric Respiratory Severity Score, PPE: parapneumonic effusion